IPXL

Impax Laboratories, Inc. News Headlines

$29.05
*  
0.13
0.45%
Get IPXL Alerts
*Delayed - data as of Jul. 11, 2014 15:44 ET  -  Find a broker to begin trading IPXL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    IPXL Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Impax Labs Appoints Frederick Wilkinson As President And CEO - Quick Facts
4/21/2014 9:01:00 AM - RTT News

Impax to Sell Authorized Generic Renvela - Analyst Blog
4/17/2014 6:14:01 PM - Zacks.com

Dr. Reddy's Launches Generic Lunesta - Analyst Blog
4/17/2014 12:44:01 PM - Zacks.com

Legal Settlement for Astellas Pharma - Analyst Blog
4/17/2014 12:41:01 PM - Zacks.com

Actelion Beats on Q1 Earnings and Sales - Analyst Blog
4/17/2014 11:00:01 AM - Zacks.com

Impax Begins Shipment Of Authorized Generic Renvela
4/16/2014 12:16:00 PM - RTT News

Regulatory Update from Impax - Analyst Blog
4/15/2014 4:55:01 PM - Zacks.com

ICPT Unveils New Data, BIO Opens Wallet, COV Recalls Devices, IPXL Resubmits NDA
4/14/2014 12:54:00 AM - RTT News

Sector Update: Healthcare Shares Lower in Pre-Market Trade
4/11/2014 8:18:36 AM - MT Newswires

Sector Update: Healthcare
4/11/2014 8:15:08 AM - MT Newswires

Pacira and Patheon Collaborate - Analyst Blog
4/8/2014 6:10:01 PM - Zacks.com

Additional Data on Pacira's Exparel - Analyst Blog
4/8/2014 5:20:01 PM - Zacks.com

Actavis Up Slightly on Silom Acquisition - Analyst Blog
4/3/2014 3:56:01 PM - Zacks.com

Millennium Management buys a position in Endo International
3/24/2014 6:58:00 PM - Market Realist

How Impax Laboratories (IPXL) Stock Stands Out in a Strong Industry - Tale of the Tape
3/14/2014 8:20:01 AM - Zacks.com

Narrower-than-Expected Loss at Supernus - Analyst Blog
3/13/2014 9:40:01 AM - Zacks.com

Pernix to Market Osmotica's Khedezla - Analyst Blog
3/3/2014 6:30:01 PM - Zacks.com

Patent Update from Mallinckrodt - Analyst Blog
2/27/2014 6:20:01 PM - Zacks.com

Legal Settlement at Endo on Lidoderm - Analyst Blog
2/24/2014 12:30:01 PM - Zacks.com

Impax Posts Loss in 4Q - Analyst Blog
2/21/2014 12:27:01 PM - Zacks.com

Market-Makers' Best Equity Bets On Presidents' Day, 2014
2/17/2014 5:06:00 AM - Seeking Alpha

Another Divestment at Actavis - Analyst Blog
1/28/2014 5:45:01 PM - Zacks.com

Allergan Slips on Restasis Challenge - Analyst Blog
1/23/2014 2:50:01 PM - Zacks.com

Mallinckrodt Up on FDA Approval - Analyst Blog
1/21/2014 1:10:01 PM - Zacks.com

Impax's Outlook for 2014 - Analyst Blog
1/16/2014 8:15:01 PM - Zacks.com